Equity (Tables)

12 Months Ended

Sep. 30, 2020

Equity [Abstract]

Schedule of Stock Options Activity

				Weighted
		Weighted		Average	Aggregate
		Average		Remaining	Intrinsic
	Number of	Exercise		Contractual Life	Value (*) (in
	Shares	Price		(in years)	thousands)
Outstanding as of September 30, 2019	51,854	$	5.00
Granted	—		—
Exercised	(650)		2.89			—
Forfeited	(1,952)		4.65
Expired	(5,187)	$	4.25
Outstanding as of September 30, 2020	44,065	$	5.14	3.70	$	—
Exercisable as of September 30, 2020	41,877	$	5.18	3.61	$	—
Vested and expected to vest as of September 30, 2020	44,065	$	5.14	3.70	$	—

(*) Intrinsic value for stock options represents the “in-the-money” portion or the positive variance between a stock option’s exercise price and the underlying stock price. For the fiscal year ended September 30, 2019, the intrinsic value of options exercised was $0.

Schedule of Restricted Stock Activity

	Restricted Stock Units			Restricted Stock Awards
	Number of	Weighted Average		Number of	Weighted Average
Restricted Stock Activity	Shares	Grant Date Fair Value		Shares	Grant Date Fair Value
Non-vested as of September 30, 2019	999,247	$	4.66	8,154	$	8.20
Granted	1,215,810	$	2.88	—	$	—
Vested	(471,208)	$	4.50	—	$	—
Forfeited	(195,804)	$	3.85	—	$	—
Non-vested as of September 30, 2020	1,548,045	$	3.41	8,154	$	8.20

Schedule of Performance Share Activity

	Performance Stock Units			Performance Stock Awards
		Weighted			Weighted
	Number of Shares	Average Grant		Number of Shares	Average Grant
Performance Stock Activity	(at Target)	Date Fair Value		(at Target)	Date Fair Value
Non-vested as of September 30, 2019	471,824	$	7.03	33,333	$	12.25
Granted	496,000	$	3.81	—	$	0.00
Vested	—	$	0.00	—	$	0.00
Forfeited	(99,324)	$	10.55	(33,333)	$	12.25
Non-vested as of September 30, 2020	868,500	$	4.79	—	$	0.00

Schedule of Stock-based Compensation Expense - By Award Type

Stock-based Compensation Expense - by award type	For the Fiscal Years ended September 30,
(in thousands)	2020		2019		2018
Employee stock options	$	13	$	25	$	32
Restricted stock units and awards		1,755		1,495		1,742
Performance stock units and awards		1,243		685		1,343
Employee stock purchase plan		214		180		276
Outside director equity awards and fees in common stock		291		221		255
Total stock-based compensation expense	$	3,516	$	2,606	$	3,648

Schedule of Stock-based Compensation Expense - By Expense Type

Stock-based Compensation Expense - by expense type	For the Fiscal Years ended September 30,
(in thousands)	2020		2019		2018
Cost of revenue	$	692	$	482	$	450
Selling, general, and administrative		2,155		1,478		2,584
Research and development		669		646		614
Total stock-based compensation expense	$	3,516	$	2,606	$	3,648

Schedule of Earnings Per Share, Basic and Diluted

Basic and Diluted Net Loss Per Share	For the Fiscal Years ended September 30,
(in thousands, except per share)	2020		2019		2018
Numerator:
Loss from operations	$	(7,000)	$	(35,984)	$	(17,453)
Undistributed earnings allocated to common shareholders for basic and diluted net income per share		(7,000)		(35,984)		(17,453)
Denominator:
Denominator for basic and fully diluted net loss per share - weighted average shares outstanding		29,136		27,983		27,266
Dilutive options outstanding, unvested stock units, unvested stock awards and ESPP		—		—		—
Denominator for diluted net loss per share - adjusted weighted average shares outstanding		29,136		27,983		27,266
Net loss per basic and fully diluted share	$	(0.24)	$	(1.29)	$	(0.64)
Weighted average antidilutive options, unvested restricted stock units and awards, unvested performance stock units and ESPP shares excluded from the computation		1,109		810		949
Average market price of common stock	$	3.03	$	3.91	$	5.87

Schedule of Common Stock Reserved for Future Issuances

	Number of Common
	Stock Shares Available for
Future Issuances	Future Issuances
Exercise of outstanding stock options	44,065
Unvested restricted stock units and awards	1,556,199
Unvested performance stock units and awards (at 200% maximum payout)	1,737,000
Purchases under the employee stock purchase plan	312,474
Issuance of stock-based awards under the Equity Plans	842,822
Purchases under the officer and director share purchase plan	88,741
Total reserved	4,581,301